The emergence of immune checkpoint inhibitors has dramatically changed the therapeutic landscape for patients with advanced melanoma. However, relatively low response rates and a high incidence of sev
This population-based retrospective cohort study uses data from the Regional Cancer Registry (RTV) of the Veneto Region (northeast Italy) to evaluate the impact of different patterns of comorbidities
Background: The incidence of cutaneous melanoma, an important global public health problem, has been increasing over the last several decades. Objectives: In order to decre
To analyse whether the activation of TGF-ß signalling (recombinant hTGF-ß, 5 ng/mL; PeproTech) is able to invoke a full phenotype- switch, we performed RNA sequencing of melanoma cultures from two ind
